Another Victory for Immune Checkpoint Blockade in Melanoma: Adjuvant Ipilimumab Over Interferon
JOURNAL OF CLINICAL ONCOLOGY (2020)
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 38, Issue 6, Pages 529-+Publisher
AMER SOC CLINICAL ONCOLOGY
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males
Mariam Saad, Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield, William A. LaFramboise, Walter Storkus, Arivarasan D. Karunamurthy, Jose Conejo-Garcia, Patrick Hwu, Howard Streicher, Vernon K. Sondak, John M. Kirkwood, Ahmad A. Tarhini
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Immune checkpoint blockade in melanoma: Advantages, shortcomings and emerging roles of the nanoparticles
Armita Mahdavi Gorabi, Mehrnaz Sadat Ravari, Mohammad-Javad Sanaei, Soodabeh Davaran, Prashant Kesharwani, Amirhossein Sahebkar
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study
Carl-Jacob Holmberg, Lars Ny, Tina J. Hieken, Matthew S. Block, Michael J. Carr, Vernon K. Sondak, Christoffer Ortenwall, Dimitrios Katsarelias, Florentia Dimitriou, Alexander M. Menzies, Robyn P. M. Saw, Aljosja Rogiers, Richard J. Straker, Giorgos Karakousis, Rona Applewaite, Lalit Pallan, Dale Han, John T. Vetto, David E. Gyorki, Emilia Nan Tie, Maria Grazia Vitale, Paulo A. Ascierto, Reinhard Dummer, Jade Cohen, Jane Y. C. Hui, Jacob Schachter, Nethanel Asher, H. Helgadottir, Harvey Chai, Hidde Kroon, Brendon Coventry, Luke D. Rothermel, James Sun, Matteo S. Carlino, Zoey Duncan, Kristy Broman, Jeffrey Weber, Ann Y. Lee, Russell S. Berman, Juri Teras, David W. Ollila, Georgina Long, Jonathan S. Zager, Alexander van Akkooi, Roger Olofsson Bagge
EUROPEAN JOURNAL OF CANCER (2022)
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review
Islam Eljilany, Arish Noor, Mahati Paravathaneni, Ibrahim Yassine, Sandra J. Lee, Megan Othus, James Moon, John M. Kirkwood, Vernon K. Sondak, Antoni Ribas, Kenneth F. Grossmann, Ahmad A. Tarhini
CANCERS (2023)
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
Chelsea A. Taylor, Robert A. Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J. Gilchrist, Alba Verge de los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A. Cooper, Victoria K. Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J. Payne, David N. Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L. Freedman, Toni K. Choueiri, Mark R. Middleton, Alexander Gusev, Benjamin P. Fairfax
NATURE MEDICINE (2022)
Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade
Paul Johannet, Wenke Liu, David Fenyo, Megan Wind-Rotolo, Michelle Krogsgaard, Janice M. Mehnert, Jeffrey S. Weber, Judy Zhong, Iman Osman
CLINICAL CANCER RESEARCH (2022)
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
Alexander X. Lozano, Aadel A. Chaudhuri, Aishwarya Nene, Antonietta Bacchiocchi, Noah Earland, Matthew D. Vesely, Abul Usmani, Brandon E. Turner, Chloe B. Steen, Bogdan A. Luca, Ti Badri, Gunsagar S. Gulati, Milad R. Vahid, Farnaz Khameneh, Peter K. Harris, David Y. Chen, Kavita Dhodapkar, Mario Sznol, Ruth Halaban, Aaron M. Newman
NATURE MEDICINE (2022)
Ag nanoparticles enhance immune checkpoint blockade efficacy by promoting of immune surveillance in melanoma
Xinwei Kuang, Zhenxing Wang, Zhongwei Luo, Zehui He, Long Liang, Qian Gao, Youyou Li, Kun Xia, Zuozhong Xie, Ruimin Chang, Yiyi Wang, Yiwei Liu, Shuang Zhao, Juan Su, Yang Wang, Weiyi Situ, Mingliang Chen, Yuetao Zhao, Xiang Chen, Hui Xie, Hong Liu
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2022)
Educational Review: Clinical Application of Immune Checkpoint Blockade for the Treatment of Melanoma
David Su, Harriet Kluger, Kelly Olino
ANNALS OF SURGICAL ONCOLOGY (2023)
Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis
Yantao Xu, Zixi Jiang, Xinwei Kuang, Xiang Chen, Hong Liu
JOURNAL OF MEDICAL INTERNET RESEARCH (2022)
Multimarker scores of Th1 and Th2 immune cellular profiles in peripheral blood predict response and immune related toxicity with CTLA4 blockade and IFNα in melanoma
Arjun Khunger, Ghanashyam Sarikonda, Jennifer Tsau, Anil Pahuja, Zeni Alfonso, Jane Gao, Christian Laing, Christine Vaupel, Naveen Dakappagari, Ahmad A. Tarhini
TRANSLATIONAL ONCOLOGY (2021)
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Douglas B. Fox, Richard Y. Ebright, Xin Hong, Hunter C. Russell, Hongshan Guo, Thomas J. LaSalle, Ben S. Wittner, Nicolas Poux, Joanna A. Vuille, Mehmet Toner, Nir Hacohen, Genevieve M. Boland, Debattama R. Sen, Ryan J. Sullivan, Shyamala Maheswaran, Daniel A. Haber
NPJ PRECISION ONCOLOGY (2023)
Immune checkpoint inhibitors in adjuvant setting after radical resection of melanoma: a meta-analysis of the pivotal trials
Melissa Bersanelli, Fausto Petrelli, Sebastiano Buti, Ignazio Stanganelli
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)
Cost-effectiveness of ipilimumab versus high-dose interferon as an adjuvant therapy in resected high-risk melanoma
Mia Salans, Patrick Travis Courtney, Anthony Yip, James D. Murphy
CANCER MEDICINE (2021)
The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition
Firas Y. Kreidieh, Hussein A. Tawbi
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2023)
Inflammatory vulvar dermatoses following immune checkpoint inhibitor therapy
Tiffany Y. Sia, Allison Betof Warner, Sarah J. Noor, Emeline M. Aviki, Kara Long Roche
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)
Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future
Allison Betof Warner, Pippa G. Corrie, Omid Hamid
CLINICAL CANCER RESEARCH (2023)
Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients
Allison Betof Warner, Ahmad Tarhini, Barinder Kang, Antonio Nakasato, You-Li Ling, Rohan Shah, Jackson Tang, Jeetvan Patel
MELANOMA RESEARCH (2023)
Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy
Thomas M. Atkinson, Jennifer L. Hay, Soo Young Kim, Elizabeth Schofield, Michael A. Postow, Parisa Momtaz, Allison Betof Warner, Alexander N. Shoushtari, Margaret K. Callahan, Jedd D. Wolchok, Yuelin Li, Paul B. Chapman
ONCOLOGIST (2023)
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
Daniel Hirschhorn, Sadna Budhu, Lukas Kraehenbuehl, Mathieu Gigoux, David Schroder, Andrew Chow, Jacob M. Ricca, Billel Gasmi, Olivier De Henau, Levi Mark B. Mangarin, Yanyun Li, Linda Hamadene, Anne-Laure Flamar, Hyejin Choi, Czrina A. Cortez, Cailian Liu, Aliya Holland, Sara Schad, Isabell Schulze, Allison Betof Warner, Travis J. Hollmann, Arshi Arora, Katherine S. Panageas, Gabrielle A. Rizzuto, Rebekka Duhen, Andrew D. Weinberg, Christine N. Spencer, David Ng, Xue-Yan He, Jean Albrengues, David Redmond, Mikala Egeblad, Jedd D. Wolchok, Taha Merghoub
CELL (2023)
Neoadjuvant relatlimab and nivolumab in resectable melanoma (vol 611, pg 155, 2022)
Rodabe N. Amaria, Michael Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos Torres-Cabala, Isabella C. Glitza, Fei Duan, Denai R. Milton, Klaus Busam, Lauren Simpson, Jennifer L. McQuade, Michael K. Wong, Jeffrey E. Gershenwald, Jeffrey E. Lee, Ryan P. Goepfert, Emily Z. Keung, Sarah B. Fisher, Allison Betof-Warner, Alexander N. Shoushtari, Margaret Callahan, Daniel Coit, Edmund K. Bartlett, Danielle Bello, Parisa Momtaz, Courtney Nicholas, Aidi Gu, Xuejun Zhang, Brinda Rao Korivi, Madhavi Patnana, Sapna P. Patel, Adi Diab, Anthony Lucci, Victor G. Prieto, Michael A. Davies, James P. Allison, Padmanee Sharma, Jennifer A. Wargo, Charlotte Ariyan, Hussein A. Tawbi
NATURE (2023)
Real-world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy
Sejin Lee, Antonia V. Bennett, Xi Zhou, Allison Betof Warner, Justin G. Trogdon, Erin E. Kent, Jennifer L. Lund
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023)
Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
Kimberly Loo, Hannah L. L. Kalvin, Katherine S. Panageas, Margaret K. K. Callahan, Paul B. B. Chapman, Parisa Momtaz, Alexander N. N. Shoushtari, Jedd D. D. Wolchok, Michael A. A. Postow, Allison Betof Warner
PIGMENT CELL & MELANOMA RESEARCH (2023)
Diversity, equity, and inclusion in the melanoma research community
Marie E. Portuallo, David Y. Lu, Gretchen M. Alicea, Joel Bolling, Rebecca Lee, Jennifer McQuade, Allison Betof Warner, Michael Davies, Ashani Weeraratna, Jessie Villanueva, Vito W. Rebecca
PIGMENT CELL & MELANOMA RESEARCH (2023)
Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study
Ryan C. Augustin, Ziyu Huang, Fei Ding, Shuyan Zhai, Jennifer McArdle, Anthony Santisi, Michael Davis, Cindy Sander, Diwakar Davar, John M. Kirkwood, Greg M. Delgoffe, Allison Betof Warner, Yana G. Najjar
FRONTIERS IN ONCOLOGY (2023)
CD4+ TIL to the Rescue of Anti-PD-1 Failure by Targeting MHC-II
Allison Betof Warner, Jason J. Luke
CLINICAL CANCER RESEARCH (2023)
Exercise as an Immune Boost: Mechanism-Driven Support for Lifestyle Interventions
Allison Betof Warner
CANCER IMMUNOLOGY RESEARCH (2023)
A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
Allison Betof Warner, Michael A. Postow, Katherine Panageas, James William Smithy, Adam Jacob Schoenfeld, Jedd D. Wolchok, Alexander Noor Shoushtari
JOURNAL OF CLINICAL ONCOLOGY (2023)
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
Adriana Hepner, Judith M. Versluis, Roslyn Wallace, Clara Allayous, Lauren Julia Brown, Claudia Trojanielloh, Camille Lea Gerardi, Yanina J. L. Jansenj, Prachi Bhave, Bart Neyns, Andrew Haydon, Olivier Michielin, Joanna Manganan Oliver Klein, Alexander N. Shoushtari, Allison Betof Warner, Paolo Antonio Ascierto, Jennifer Leigh McQuade, Matteo S. Carlino, Lisa Zimmer, Celeste Lebbe, Douglas B. Johnson, Shahneen Sandhu, Victoria Atkinson, Christian U. Blank, Serigne N. Lo, Georgina V. Long, Alexander M. Menzies
EUROPEAN JOURNAL OF CANCER (2024)
Leptomeningeal Carcinomatosis from Solid Tumor Malignancies: Treatment Strategies and Biomarkers
Rachna Malani, Ankush Bhatia, Allison Betof Warner, Jonathan T. Yang
SEMINARS IN NEUROLOGY (2023)